NCT01801176

Peripheral Primitive Fibromatosis

Peripheral Primitive Fibromatosis. Study Evaluating a Simple Initial Monitoring With Search of Scalability Predictive Factors and Registration of Treatments in Case of Progression

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

It's a monitoring study. The aim is to assess the progression free survival up to 3 years. Patients are not treated until progression. Search for scalability predictive factors and registration of treatments if progression.

Conditions

• Peripheral Primitive Fibromatosis

Interventions

Type	Name	Description
OTHER	MRI	MRI every 3 months during the first year and then every 6 months during the second year and then one MRI up to 36 months

Timeline

• Start date: 2012-06-11
• Primary completion: 2020-05-25
• Completion: 2020-12-02
• First posted: 2013-02-28
• Last updated: 2026-04-06

Locations

1 site across 1 country: France